Molecular Characterization of Cutaneous Tumors

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03092830

Enrollment

500

Registered

2017-03-28

Start date

2017-03-29

Completion date

2020-08-07

Last updated

2019-04-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Basal Cell Carcinoma, Squamous Cell Carcinoma

Keywords

SCC, BCC, DNA, RNA, HEDGE HOG, epidermal growth factor receptor

Brief summary

The objective is to find genes which are responsible for the appearance of skin tumors (sCC, BCC) and it will be the basis for prediction of the disease and response to the treatment

Detailed description

Prospective, 1-arm, 500 participates above 18 age with skin tumor affliction sCC and BCC type.

Interventions

GENETICMolecular testing of DNA/RNA from skin tumors, SCC/BCC

Molecular testing of DNA/RNA from skin tumors, SCC/BCC

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* patient that have sCC and BCC tumors * above 18 years old

Exclusion criteria

* below 18 years old * pregnant women * children or person without judgment ability

Design outcomes

Primary

Measure	Time frame	Description
Molecular Characterization of cutaneous tumors	5 years	samples from subjects

Countries

Israel

Contacts

Primary ContactDR Dean Ad EL, MD

deana@clalit.org.il+972-3-9376366

Backup ContactDR Asaf Olshinka, MD

+972-3-9376366

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026